医学
易普利姆玛
彭布罗利珠单抗
临床试验
内科学
肿瘤科
黑色素瘤
免疫疗法
无容量
癌症
癌症研究
作者
Laurent Dercle,Binsheng Zhao,Mithat Gönen,Chaya S. Moskowitz,Firas Ahmed,Volkan Beylergil,Dana E. Connors,Hao Yang,Lin Lü,Tito Fojo,Richard D. Carvajal,Sanja Karovic,Michael L. Maitland,Gregory Goldmacher,Geoffrey R. Oxnard,Michael A. Postow,Lawrence H. Schwartz
出处
期刊:JAMA Oncology
[American Medical Association]
日期:2022-01-20
卷期号:8 (3): 385-385
被引量:87
标识
DOI:10.1001/jamaoncol.2021.6818
摘要
The findings of this prognostic study suggest that the radiomic signature discerned from conventional CT images at baseline and on first follow-up may be used in clinical settings to provide an accurate early readout of future OS probability in patients with melanoma treated with single-agent programmed cell death 1 blockade.
科研通智能强力驱动
Strongly Powered by AbleSci AI